By Professor Phillip David Stricker

Book Chapters

van Leeuwen PJ; Roobol MJ; Stricker PD, 2018, 'Early detection and screening for prostate cancer', in , Wiley, pp. 255 - 264, http://dx.doi.org/10.1002/9781119129875.ch22

Journal articles

Peters TJ; Meyer B; Ryan L; Achinger-Kawecka J; Song J; Campbell EM; Qu W; Nair S; Loi-Luu P; Stricker P; Lim E; Stirzaker C; Clark SJ; Pidsley R, 2024, 'Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling', BMC Genomics, 25, http://dx.doi.org/10.1186/s12864-024-10027-5

Huang R; Bornman MSR; Stricker PD; Simoni Brum I; Mutambirwa SBA; Jaratlerdsiri W; Hayes VM, 2024, 'The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-57566-1

Li S; Nguyen A; Counter W; John NC; De Leon J; Hruby G; Joshua AM; Stricker P; Crumbaker M; Ayati N; Chan L; Sabahi Z; Swiha M; Kneebone A; Wong K; Liu V; Sharma S; Agrawal S; Emmett LM, 2024, 'Utility of ⁶⁴Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on ⁶⁸Ga-PSMA-11 PET/CT', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 65, pp. 1371 - 1375, http://dx.doi.org/10.2967/jnumed.124.267881

Zhang K; Stricker P; Löhr M; Stehling M; Suberville M; Cussenot O; Lunelli L; Ng CF; Teoh J; Laguna P; de la Rosette J, 2024, 'A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer', Prostate Cancer and Prostatic Diseases, 27, pp. 525 - 530, http://dx.doi.org/10.1038/s41391-023-00783-y

Bancroft EK; Page EC; Brook MN; Pope J; Thomas S; Myhill K; Helfand BT; Talaty P; Ong KR; Douglas E; Cook J; Rosario DJ; Salinas M; Buys SS; Anson J; Davidson R; Longmuir M; Side L; Eccles DM; Tischkowitz M; Taylor A; Cruellas M; Ballestero EP; Cleaver R; Varughese M; Barwell J; LeButt M; Greenhalgh L; Hart R; Azzabi A; Jobson I; Cogley L; Evans DG; Rothwell J; Taylor N; Hogben M; Saya S; Kote-Jarai Z; Ardern-Jones A; Bangma C; Castro E; Dearnaley D; Eyfjord J; Falconer A; Foster C; Grönberg H; Hamdy FC; Jóhannsson ÓÞ; Khoo V; Lilja H; Lindeman G; Lubinski J; Maehle L; Millner A; Mikropoulos C; Mitra A; Moynihan C; Offman J; Rennert G; Suri M; Wilson P; Melia J; Mitchell G; Moss S; Schroder F; Easton D; Peock S; Sibley P; Sharifi R; James P; Shanley S; Richardson K; McKinley J; Petelin L; Murphy M; Mascarenhas L; Reeve K; Murphy D; Lam J; Chong M; Suthers G; Poplawski N; Ward R; Tucker K; Andrews L; Williams R; Duffy J; Millard R; Jarvis T; Stricker P; Kirk J; Bowman M; Patel M; Harris M; O'Connell S; Hunt C; Smyth C; Frydenberg M; Morton C; Shackleton K, 2024, 'The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers', BJU International, 134, pp. 484 - 500, http://dx.doi.org/10.1111/bju.16432

Emmett L; Papa N; Hope TA; Fendler W; Calais J; Burger I; Eiber M; Barbato F; Moon D; Counter W; John N; Xue A; Franklin A; Thompson J; Rasiah K; Frydenberg M; Yaxley J; Buteau J; Agrawal S; Ho B; Nguyen A; Liu V; Lee J; Woo H; Hsiao E; Sutherland T; Perry E; Stricker P; Hofman MS; Kasivisvanathan V; Roberts M; Murphy D, 2024, 'Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer', Journal of Urology, 212, pp. 299 - 307, http://dx.doi.org/10.1097/JU.0000000000004010

Berrens AC; Scheltema M; Maurer T; Hermann K; Hamdy FC; Knipper S; Dell’Oglio P; Mazzone E; de Barros HA; Sorger JM; van Oosterom MN; Stricker PD; van Leeuwen PJ; Rietbergen DDD; Valdes Olmos RA; Vidal-Sicart S; Carroll PR; Buckle T; van der Poel HG; van Leeuwen FWB, 2024, 'Delphi consensus project on prostate-specific membrane antigen (PSMA)–targeted surgery—outcomes from an international multidisciplinary panel', European Journal of Nuclear Medicine and Molecular Imaging, 51, pp. 2893 - 2902, http://dx.doi.org/10.1007/s00259-023-06524-6

Buteau JP; Moon D; Fahey MT; Roberts MJ; Thompson J; Murphy DG; Papa N; Mitchell C; De Abreu Lourenco R; Dhillon HM; Kasivisvanathan V; Francis RJ; Stricker P; Agrawal S; O'Brien J; McVey A; Sharma G; Levy S; Ayati N; Nguyen A; Lee SF; Pattison DA; Sivaratnam D; Frydenberg M; Du Y; Titus J; Lee ST; Ischia J; Jack G; Hofman MS; Emmett L, 2024, 'Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [⁶⁸Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer', European urology oncology, 7, pp. 544 - 552, http://dx.doi.org/10.1016/j.euo.2023.11.008

Hassan SP; de Leon J; Batumalai V; Moutrie Z; Hogan L; Ge Y; Stricker P; Jameson MG, 2024, 'Magnetic resonance guided adaptive post prostatectomy radiotherapy: Accumulated dose comparison of different workflows', Journal of Applied Clinical Medical Physics, 25, http://dx.doi.org/10.1002/acm2.14253

Geboers B; Meijer D; Counter W; Blazevski A; Thompson J; Doan P; Gondoputro W; Katelaris A; Haynes AM; Delprado W; O'Neill G; Yuen C; Vis AN; van Leeuwen PJ; Ho B; Liu V; Lee J; Donswijk ML; Oprea-Lager D; Scheltema MJ; Emmett L; Stricker PD, 2024, 'Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy', BJU International, 133, pp. 14 - 22, http://dx.doi.org/10.1111/bju.16207

Geboers B; Scheltema MJV; Emmett L; Stricker PD, 2024, 'Reply to ‘Re: Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy’', BJU International, 133, pp. 25 - 26, http://dx.doi.org/10.1111/bju.16308

Pidsley R; Lam D; Qu W; Stricker P; Kench JG; Horvath LG; Clark SJ, 2024, 'Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer', BJUI Compass, http://dx.doi.org/10.1002/bco2.445

Geboers B; Scheltema MJ; Jung J; Bakker J; Timmer FEF; Cerutti X; Katelaris A; Doan P; Gondoputro W; Blazevski A; Agrawal S; Matthews J; Haynes AM; Robertson T; Thompson JE; Meijerink MR; Clark SJ; de Gruijl TD; Stricker PD, 2024, 'Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation – IRE-IMMUNO study', BJU International, http://dx.doi.org/10.1111/bju.16496

Emmett L; Papa N; Counter W; Calais J; Barbato F; Burger I; Eiber M; Roberts MJ; Agrawal S; Franklin A; Xue A; Rasiah K; John N; Moon D; Frydenberg M; Yaxley J; Stricker P; Wong K; Coughlin G; Gianduzzo T; Kua B; Ho B; Nguyen A; Liu V; Lee J; Hsiao E; Sutherland T; Perry E; Fendler WP; Hope TA, 2024, 'Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database', Journal of Nuclear Medicine, 65, http://dx.doi.org/10.2967/jnumed.123.266164

Storino Ramacciotti L; Abreu AL; Crouzet S; Macek P; Miles BJ; Horuz R; Nunes-Carneiro D; Stricker P; Scionti S; Laguna MP, 2024, 'Salvage treatments after focal therapy for prostate cancer – a comprehensive review', Prostate Cancer and Prostatic Diseases, http://dx.doi.org/10.1038/s41391-024-00875-3

Emmett L; Papa N; Hope T; Fendler W; Calais J; Burger I; Eiber M; Barbato F; Moon D; Xue A; Franklin A; Thompson J; Rasiah K; Frydenberg M; Yaxley J; Buteau J; Liu V; Nguyen A; Hsiao E; Stricker P; Hofman M; Kasivisvanathan V; Roberts M; Murphy D, 2024, 'Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer', European Urology, 85, pp. S476 - S476, http://dx.doi.org/10.1016/s0302-2838(24)00417-2

Vis A; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; Van Der Ven PM; Heymans MW; Nieuwenhuijzen JA; Van Der Poel HG; Van Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes A-M; Oprea-Lager DE; Coughlin GD; Van Leeuwen PJ, 2024, 'Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission', European Urology, 85, pp. S483 - S484, http://dx.doi.org/10.1016/s0302-2838(24)00422-6

Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ, 2023, 'Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography', European urology oncology, 6, pp. 553 - 563, http://dx.doi.org/10.1016/j.euo.2023.03.010

Deivasigamani S; Kotamarti S; Rastinehad AR; Salas RS; de la Rosette JJMCH; Lepor H; Pinto P; Ahmed HU; Gill I; Klotz L; Taneja SS; Emberton M; Lawrentschuk N; Wysock J; Feller JF; Crouzet S; Kumar M. P; Seguier D; Adams ES; Michael Z; Abreu A; Jack Tay K; Ward JF; Shinohara K; Katz AE; Villers A; Chin JL; Stricker PD; Baco E; Macek P; Ahmad AE; Chiu PKF; Crawford ED; Rogers CG; Futterer JJ; Rais-Bahrami S; Robertson CN; Hadaschik B; Marra G; Valerio M; Chong KT; Kasivisvanathan V; Tan WP; Lomas D; Walz J; Guimaraes GC; Mertziotis NI; Becher E; Finelli A; Kasraeian A; Lebastchi AH; Vora A; Rosen MA; Bakir B; Arcot R; Yee S; Netsch C; Meng X; de Reijke TM; Tan YG; Regusci S; Benjamin TGR; Olivares R; Noureldin M; Bianco FJ; Sivaraman A; Kim FJ; Given RW; Dason S; Sheetz TJ; Shoji S; Schulman A; Royce P; Shah TT; Scionti S; Salomon G; Laguna P; Tourinho-Barbosa R; Aminsharifi A; Cathelineau X; Gontero P; Stabile A; Grummet J; Ledbetter L; Graton M; Stephen Jones J; Polascik TJ, 2023, 'Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement', European Urology, 84, pp. 547 - 560, http://dx.doi.org/10.1016/j.eururo.2023.06.013

Doan P; Katelaris A; Scheltema MJ; Hayen A; Amin A; Siriwardana A; Tran M; Geboers B; Gondoputro W; Haynes AM; Matthews J; Delprado W; Stricker PD; Thompson J, 2023, 'The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer', BMC Urology, 23, http://dx.doi.org/10.1186/s12894-023-01228-3

Williams ISC; Katelaris A; Geboers B; Doan P; Delprado W; Scheltema MJ; Stricker PD, 2023, 'Transrectal Ultrasound as Real-Time Confirmation of Adequate Needle Positioning During Irreversible Electroporation in Focal Therapy of Prostate Cancer', Videourology, 37, pp. 1 - 2, http://dx.doi.org/10.1089/vid.2023.0046

Gondoputro W; Doan P; Katelaris A; Scheltema MJ; Geboers B; Agrawal S; Liu Z; Yaxley J; Savdie R; Rasiah K; Frydenberg M; Roberts MJ; Malouf D; Wong D; Shnier R; Delprado W; Emmett L; Stricker PD; Thompson J, 2023, '⁶⁸Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study', Translational Andrology and Urology, 12, pp. 1598 - 1606, http://dx.doi.org/10.21037/tau-22-708

Azargoshasb S; de Barros HA; Rietbergen DDD; Dell’Oglio P; van Leeuwen PJ; Wagner C; Stricker P; Vidal-Sicart S; Briganti A; Maurer T; van der Poel HG; van Oosterom MN; van Leeuwen FWB, 2023, 'Artificial Intelligence-Supported Video Analysis as a Means to Assess the Impact of DROP-IN Image Guidance on Robotic Surgeons: Radioguided Sentinel Lymph Node versus PSMA-Targeted Prostate Cancer Surgery', Advanced Intelligent Systems, 5, http://dx.doi.org/10.1002/aisy.202300192

Scheltema MJ; Katelaris A; Stricker PD, 2023, 'Salvage irreversible electroporation for radio-recurrent prostate cancer', Nature Reviews Urology, 20, pp. 517 - 518, http://dx.doi.org/10.1038/s41585-023-00750-1

Kelly BD; Ptasznik G; Roberts MJ; Doan P; Stricker P; Thompson J; Buteau J; Chen K; Alghazo O; O'Brien JS; Hofman MS; Frydenberg M; Lawrentschuk N; Lundon D; Murphy DG; Emmett L; Moon D, 2023, 'A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy', European Urology Open Science, 53, pp. 90 - 97, http://dx.doi.org/10.1016/j.euros.2023.05.002

Craddock J; Jiang J; Patrick SM; Mutambirwa SBA; Stricker PD; Bornman MSR; Jaratlerdsiri W; Hayes VM, 2023, 'Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities', Cancers, 15, http://dx.doi.org/10.3390/cancers15133462

Best O; Canagasingham A; Liu Z; Doan P; Haynes AM; Delprado W; Maclean F; Yuen C; Stricker P; Thompson J, 2023, 'Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy', Pathology, 55, pp. 492 - 497, http://dx.doi.org/10.1016/j.pathol.2022.10.012

Geboers B; Scheltema MJ; Blazevski A; Katelaris A; Doan P; Ali I; Agrawal S; Barreto D; Matthews J; Haynes AM; Delprado W; Shnier R; Thompson JE; Stricker PD, 2023, 'Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer', BJU International, 131, pp. 14 - 22, http://dx.doi.org/10.1111/bju.15948

Scheltema MJ; Geboers B; Blazevski A; Doan P; Katelaris A; Agrawal S; Barreto D; Shnier R; Delprado W; Thompson JE; Stricker PD, 2023, 'Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer', BJU International, 131, pp. 6 - 13, http://dx.doi.org/10.1111/bju.15946

Blazevski A; Geboers B; Scheltema MJ; Gondoputro W; Doan P; Katelaris A; Agrawal S; Baretto D; Matthews J; Haynes AM; Delprado W; Shnier R; van den Bos W; Thompson JE; Lawrentschuk N; Stricker PD, 2023, 'Salvage irreversible electroporation for radio-recurrent prostate cancer – the prospective FIRE trial', BJU International, 131, pp. 23 - 31, http://dx.doi.org/10.1111/bju.15947

Lantz A; Nordlund P; Falagario U; Jäderling F; Özbek O; Clements M; Discacciati A; Grönberg H; Eklund M; Stricker P; Emberton M; Aly M; Nordström T, 2023, 'Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer', European Urology Open Science, 51, pp. 89 - 94, http://dx.doi.org/10.1016/j.euros.2023.03.003

Doan P; Counter W; Papa N; Sheehan-Dare G; Ho B; Lee J; Liu V; Thompson JE; Agrawal S; Roberts MJ; Buteau J; Hofman MS; Moon D; Lawrentschuk N; Murphy D; Stricker PD; Emmett L, 2023, 'Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer', BJU International, 131, pp. 588 - 595, http://dx.doi.org/10.1111/bju.15929

Katelaris A; Amin A; Blazevski A; Scheltema MJ; Cusick T; Farraha M; Barreto D; Haynes AM; Gondoputro W; Agrawal S; Stricker P; Thompson J, 2023, 'Outcomes for active surveillance are similar for men with favourable risk ISUP-2 to those with ISUP-1 prostate cancer: A pair matched cohort study', Journal of Clinical Urology, http://dx.doi.org/10.1177/20514158231154702

Buteau JP; Moon D; Fahey MT; Roberts M; Thompson J; Murphy DG; Papa N; Mitchell C; Kasivisvanathan V; Stricker P; O'Brien J; Counter W; Sharma G; Agrawal S; Ho B; Yeung T; De Abreu Lourenço R; Dhillon HM; Hofman MS; Emmett L, 2023, 'PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [⁶⁸Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer.', Journal of Clinical Oncology, 41, pp. TPS397 - TPS397, http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps397

Ong S; Chen K; Grummet J; Yaxley J; Scheltema MJ; Stricker P; Tay KJ; Lawrentschuk N, 2023, 'Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?', BJU International, 131, pp. 20 - 31, http://dx.doi.org/10.1111/bju.15883

Li L; Shiradkar R; Tirumani SH; Bittencourt LK; Fu P; Mahran A; Buzzy C; Stricker PD; Rastinehad AR; Magi-Galluzzi C; Ponsky L; Klein E; Purysko AS; Madabhushi A, 2023, 'Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer', European Journal of Radiology Open, 10, http://dx.doi.org/10.1016/j.ejro.2023.100496

Rodríguez-Sánchez L; Emberton M; de Reijke T; Stricker P; Miñana B; Bianco F; Escrig JLD; Lantz A; Sanchez-Salas R, 2023, 'Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer', World Journal of Men's Health, 41, pp. 1 - 11, http://dx.doi.org/10.5534/wjmh.230160

Azargoshasb S; de Barros HA; Rietbergen DDD; Dell’Oglio P; van Leeuwen PJ; Wagner C; Stricker P; Vidal-Sicart S; Briganti A; Maurer T; van der Poel HG; van Oosterom MN; van Leeuwen FWB, 2023, 'Artificial Intelligence‐Supported Video Analysis as a Means to Assess the Impact of DROP‐IN Image Guidance on Robotic Surgeons: Radioguided Sentinel Lymph Node versus PSMA‐Targeted Prostate Cancer Surgery', Advanced Intelligent Systems, 5, http://dx.doi.org/10.1002/aisy.202370044

Berrens AC; Scheltema M; Maurer T; Hermann K; Hamdy FC; Knipper S; Dell’Oglio P; Mazzone E; de Barros HA; Sorger JM; van Oosterom MN; Stricker PD; van Leeuwen PJ; Rietbergen D; Valdes Olmos R; Vidal-Sicart S; Carroll PR; Buckle T; van der Poel HG; van Leeuwen FWB, 2023, 'Delphi Consensus Project on Prostate-specific Membrane Antigen (PSMA)-Targeted Surgery – outcomes from an international multidisciplinary panel', European Urology Open Science, 57, pp. S122 - S122, http://dx.doi.org/10.1016/s2666-1683(23)01379-4

Scheltema MJV; Geboers B; Meijer D; Counter W; Thompson J; Doan P; Gondoputro W; Katelaris A; Haynes AM; Delprado W; Vis A; van Leeuwen P; Ho B; Liu V; Lee J; Donswijk M; Oprea-Lager D; Emmett L; Stricker P, 2023, 'The value of PSMA-PET in Addition to mpMRI and Systematic Biopsies to Select Patients for Hemi-ablative Focal Therapy in Prostate Cancer', European Urology Open Science, 57, pp. S45 - S45, http://dx.doi.org/10.1016/s2666-1683(23)01325-3

Gong T; Jaratlerdsiri W; Jiang J; Willet C; Chew T; Patrick SM; Lyons RJ; Haynes AM; Pasqualim G; Brum IS; Stricker PD; Mutambirwa SBA; Sadsad R; Papenfuss AT; Bornman RMS; Chan EKF; Hayes VM, 2022, 'Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers', Genome Medicine, 14, http://dx.doi.org/10.1186/s13073-022-01096-w

Iczkowski KA; Molina M; Egevad L; Bostwick DG; van Leenders GJLH; La Rosa FG; van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Leite KRM; Samaratunga H; Srigley J; Varma M; Tsuzuki T; Lucia MS; Crawford ED; Harris RG; Stricker P; Lawrentschuk N; Woo HH; Fleshner NE; Shore ND; Yaxley J; Bratt O; Wiklund P; Roberts M; Cheng L; Delahunt B, 2022, 'Low-grade prostate cancer should still be labelled cancer', BJU International, 130, pp. 741 - 743, http://dx.doi.org/10.1111/bju.15886

Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes AM; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker PD, 2022, 'Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes', BMC Urology, 22, http://dx.doi.org/10.1186/s12894-022-00978-w

Geboers B; Gondoputro W; Thompson JE; Reesink DJ; van Riel LAMJG; Zhang D; Blazevski A; Doan P; Agrawal S; Matthews J; Haynes AM; Liu Z; Delprado W; Shnier R; de Reijke TM; Lawrentschuk N; Stijns PEF; Yaxley JW; Scheltema MJ; Stricker PD, 2022, 'Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study', European Urology Focus, 8, pp. 1591 - 1598, http://dx.doi.org/10.1016/j.euf.2022.04.010

Roberts MJ; Chatfield MD; Hruby G; Nandurkar R; Roach P; Watts JA; Cusick T; Kneebone A; Eade T; Ho B; Nguyen A; Tang C; McCarthy M; Francis R; Stricker P; Emmett L, 2022, 'Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups', BJU International, 130, pp. 32 - 39, http://dx.doi.org/10.1111/bju.15762

Doan P; Scheltema MJ; Amin A; Shnier R; Geboers B; Gondoputro W; Moses D; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O’Neill G; Yuen C; Delprado W; Stricker P; Thompson J, 2022, 'Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial', Journal of Urology, 208, pp. 1028 - 1036, http://dx.doi.org/10.1097/JU.0000000000002885

Ptasznik G; Papa N; Kelly BD; Thompson J; Stricker P; Roberts MJ; Hofman MS; Buteau J; Murphy DG; Emmett L; Moon D, 2022, 'High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer', BJU International, 130, pp. 5 - 7, http://dx.doi.org/10.1111/bju.15736

van Riel LAMJG; Geboers B; Kabaktepe E; Blazevski A; Reesink DJ; Stijns P; Stricker PD; Casanova J; Dominguez-Escrig JL; de Reijke TM; Scheltema MJ; Oddens JR, 2022, 'Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer', BJU International, 130, pp. 611 - 618, http://dx.doi.org/10.1111/bju.15759

Emmett L; Papa N; Buteau J; Ho B; Liu V; Roberts M; Thompson J; Moon D; Sheehan-Dare G; Alghazo O; Agrawal S; Murphy D; Stricker P; Hope TA; Hofman MS, 2022, 'The PRIMARY Score: Using Intraprostatic ⁶⁸Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 63, pp. 1644 - 1650, http://dx.doi.org/10.2967/jnumed.121.263448

Back to profile page